AI-generated summary
The authors reviewed published studies on low-level laser therapy in multiple sclerosis, searching Google Scholar, PubMed and Medline. They report that the therapy reduced inflammatory immune cells and mediators and enhanced neuron regeneration, and they suggest it could be a promising approach alongside current treatments.
- Who or what was studied
- People with multiple sclerosis, based on published studies identified in the review
- Limits stated in the abstract
- The abstract describes a narrative review and does not report the number of included studies, their design, or the certainty of the evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.